Risk-factor control and secondary prevention in ischaemic heart disease in primary care: real-world insights from QregPV
Combined risk-factor control was low, largely due to low LDL-C control, despite high LLT usage. Risk-factor control and the use of LLT and ATT varied between PHCCs and were lower in women than men. Concrete clinical strategies for attaining risk-factor goals in both sexes and for reducing PHCC variation are warranted.
Authors
- Koen Simons (ORCID: https://orcid.org/0000-0002-6534-2277)
- Johan‐Emil Bager (ORCID: https://orcid.org/0000-0002-7771-7216)
- Annika Rosengren (ORCID: https://orcid.org/0000-0002-5409-6605)
- Tobias Andersson (ORCID: https://orcid.org/0000-0003-1419-8460)
- Maria Åberg (ORCID: https://orcid.org/0000-0002-0323-1061)
- Georgios Mourtzinis (ORCID: https://orcid.org/0000-0003-0147-8746)
Institutions
- National Academy of Medicine (US)
- Sahlgrenska University Hospital (SE)
- Region Västra Götaland (SE)
- Business Region Göteborg (Sweden) (SE)
- Skaraborg Hospital (SE)
- University of Gothenburg (SE)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1093/eurjpc/zwaf052
- Citations
- 4
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 12.52
Funders
- Vetenskapsrådet
- Göteborgs Läkaresällskap
- Sahlgrenska Universitetssjukhuset